Aravive, Inc. Common Stock
ARAV
ARAV was delisted on the 26th of January, 2024.
51 hedge funds and large institutions have $30.6M invested in Aravive, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 19 reducing their positions, and 11 closing their positions.
47% more call options, than puts
Call options by funds: $91K | Put options by funds: $62K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 11
2% less funds holding
Funds holding: 52 → 51 (-1)
21% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 19
68% less capital invested
Capital invested by funds: $96.6M → $30.6M (-$66M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.05M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$635K |
| 3 |
Two Sigma Advisers
New York
|
+$525K |
| 4 |
Two Sigma Investments
New York
|
+$428K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$293K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$11.2M |
| 2 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$6.71M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$2M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$1.19M |
| 5 |
SCM
Sio Capital Management
New York
|
-$796K |
ARAV Hedge Fund Activity: Q3 2020 in Review
51 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Aravive, Inc. Common Stock (ARAV) for Q3 2020, worth a combined $30.6M — down 68% from $96.6M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of ARAV and 10 opened new positions — a net loss of 1 holder — while 19 trimmed existing stakes and 15 added.
The largest buyer was Renaissance Technologies, adding an estimated $1.05M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $11.2M sold.
- 51 institutional investors held Aravive, Inc. Common Stock (ARAV) as of Q3 2020, down from 52 in Q2 2020.
- Funds reported $30.6M of Aravive, Inc. Common Stock stock for Q3 2020, down 68% quarter-over-quarter.
- 10 funds opened new Aravive, Inc. Common Stock positions in Q3 2020 and 11 closed out, a net change of -1 holder.
- The largest Aravive, Inc. Common Stock buyer in Q3 2020 was Renaissance Technologies, an estimated $1.05M added.
- The largest Aravive, Inc. Common Stock seller in Q3 2020 was Consonance Capital Management, an estimated $11.2M sold.
Based on aggregated 13F filings for Q3 2020.